Spiked tibial cement spacer provides superior stability than conventional design in 2stage Revision TKA

Written By :  Dr Supreeth D R
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-09-30 14:15 GMT   |   Update On 2022-10-01 09:06 GMT

Articulating cement spacers are frequently used in staged approaches for infected total knee arthroplasty (TKA). Kwang Hwan Jung et al conducted a study to investigate whether a tibial cement spacer (TCS) with spikes could reduce spacer-related problems in two-stage revision TKA (R-TKA).The article has been published in "International Orthopaedics" journal.A total of 27 patients (27 knees; 10...

Login or Register to read the full article

Articulating cement spacers are frequently used in staged approaches for infected total knee arthroplasty (TKA). Kwang Hwan Jung et al conducted a study to investigate whether a tibial cement spacer (TCS) with spikes could reduce spacer-related problems in two-stage revision TKA (R-TKA).The article has been published in "International Orthopaedics" journal.

A total of 27 patients (27 knees; 10 men and 17 women) who underwent two-stage R-TKA for infected TKA were retrospectively analyzed. Group A comprised 12 patients who used TCS with spikes added to the bottom surface, whereas group B consisted of 15 patients who used conventional TCS with a flat bottom (FCS). For each group, plain radiographs were obtained after cement spacer implantation and before R-TKA to measure mediolateral (ML) translation and TCS's tilting angle. Patients' demographic data, ML translation of the TCS, and changes in the TCS's tilting angle between the groups were analyzed.

Spacer design

The authors chose commercial bone cement (Simplex® HV with gentamicin; Stryker, Kalamazoo, MI, USA) that was based on poly (methyl methacrylate), had a powder-to-liquid ratio of 2:1, and had an antibiotic-to-bone cement ratio of 1:50 per package. If a specific culture organism was known preoperatively, directed antibiotic choices were made; if the organism was unknown, the formula for antibiotics was based on 1 g of meropenem and 1 g of vancomycin per package. Additional antibiotics were mixed with bone cement containing 0.8 g of gentamycin sulfate. All cement spacers were molded intra-operatively using knee cement spacer molds, which allowed for FCS and TCS sizes ranging from 66 to 76 mm and 62 to 68 mm, respectively. Adequate thickness of the TCS was determined under traction of the leg at full extension and flexion of the knee joint at 90° to achieve gap balancing. Immediately prior to cement hardening, several spikes were made using a surgical probe on the bottom surface of the TCS. In the control group with a flat bottom, the cement was naturally hardened and used without performing the aforementioned technique.

The results of the study were:

• The mean patient age was 74.5 (range, 63–85) years in group A and 73.5 (range, 60–81) years in group B (p=0.96).

• No significant difference in the thickness of the polyethylene inserted in the previous primary TKA was identified

• There were no statistically significant differences in WBC count, ESR, and CRP level between the two groups

• The mean ML translation was significantly lower in group A than that in group B (1.7 mm vs. 5.4 mm, p=0.04).

• The mean change in the tilting angle was significantly lower in group A than that in group B (4.5° vs. 19.4°, p=0.047).

The authors concluded that - The spiked TCS in two-stage R-TKA is easy to fabricate and provides superior stability compared to the TCS with a conventional design.

Further reading:

Does spiked tibial cement spacer reduce spacer related problems in two stage revision total knee arthroplasty for infection? Kwang Hwan Jung, Chae Chil Lee et al, International Orthopaedics (2022) 46:2009–2017 https://doi.org/10.1007/s00264-022-05438-6

Tags:    
Article Source : International Orthopaedics

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News